Thank you for joining us at the Alliance for Cancer Gene Therapy Summit 2026.
The ACGT Summit is an annual invitation-only event in recognition of ACGT’s mission to advance research to develop curative cell and gene therapies for cancer.
ACGT Summit 2026 brings ACGT’s Research Fellows together with our esteemed Scientific Advisory Council, Board of Directors, Alliance Partners and other important thought-leaders in the cell and gene therapy field to engage in a series of panels and discussions designed to forward the development of new life-saving cell and gene therapies focusing on solid tumors.
ACGT’s alliance of researchers, clinicians, companies, and non-profit partners have the opportunity to hear from the trailblazers driving clinical advances. Attendees participate in working sessions focused on breaking down barriers, enabling collaborations and expediting breakthroughs.
ACGT Summit 2026 Sponsors
We are grateful to our 2026 sponsors and thank them for their support!
Featured Speakers
Jeff Allen, Friends of Cancer Research
Gilles Besin, MD, Bristol Myers Squibb
Becky Bish, PhD, The Mark Foundation for Cancer Research
Michael Birnbaum, PhD, MIT
Emily Bosco, PhD, AstraZeneca
Jennifer Brogdon, PhD, Novartis
Brian Brown, PhD, Mount Sinai
Christine Brown, PhD, City of Hope
Renier Brentjens, MD, PhD, Roswell Park
Yvonne Chen, PhD, University of California, Los Angeles
Sidi Chen, PhD, Yale School of Medicine
Mark Cobbold, MD, PhD, AstraZeneca
John Connolly, PhD, Parker Institute for Cancer Immunotherapy
May Daher, MD, MD Anderson
Marc Engelsgjerd, MD, Royalty Pharma
Joseph Fraietta, PhD, University of Pennsylvania
Juan Fueyo, MD, MD Anderson Cancer Center
Phillip Greenberg, MD, PhD, Fred Hutch
Stephen Gottschalk, MD, St Jude Children’s Research Hospital
John Higgins, Brain Tumor Investment Fund
Christian Hinrichs, MD, Rutgers Cancer Institute
Madan Jagasia, MD, Obsidian Therapeutics
Conley Jones, Alexandria Venture Investments
Lex Johnson, PhD, Dispatch Bio
Carl June, MD, University of Pennsylvania
Meisam Naeimi Kararoudi, PhD, CARTx, Cincinnati Children’s Hospital
Bruce Levine, PhD, University of Pennsylvania
Michael T. Lotze, MD, University of Pittsburgh
Crystal Mackall, MD, Stanford University
Marcela Maus, MD, PhD, Mass General Hospital
Ira Mellman, PhD, Medici Therapeutics, Parker Institute for Cancer Immunotherapy
Michael Mitchell, PhD, University of Pennsylvania
Hideho Okada, MD, PhD, University of California, San Francisco
Donald M. O’Rourke, MD, University of Pennsylvania
Stephen Russell, MD, PhD, Vyriad
Michel Sadelain, MD, PhD, Columbia University
Sheila Singh, MD, PhD, King’s College London
Ying K. Tam, PhD, Acuitas Therapeutics
Anna Turetsky, PhD, OUP (PxB Fund)
Bradley Watts, CAR T-cell patient